Tahoe Therapeutics, which is building AI models of living cells, raised $30M led by Amplify Partners at a $120M valuation, taking its total funding to $42M
The Palo Alto, California-based company, now valued at $120 million, has developed a scalable way to quickly generate crucial biological data needed …
New from me: Tahoe Therapeutics raised a $30 million funding round with a goal of building up the data needed to digitally simulate cancer cells as a way to speed up the process of developing new medicines. — www.forbes.com/sites/alexkn...